daratumumab,talquetamab,teclistamab
janssen,genmab
['mmsm', 'redirectt-1']
#mmsm #asco23 plasma cell dyscrasia oral session -redirectt-1 study design and end points notice the dosing schedule every 2 weeks 
Assistant professor @UAMSMyeloma. Alumni heme/onc @bcmhouston, clinical research/biostat @UMich.Focus on plasma cell disorders & health disparities